Gomis-González, M.; Busquets-Garcia, A.; Matute, C.; Maldonado, R.; Mato, S.; Ozaita, A.
Possible Therapeutic Doses of Cannabinoid Type 1 Receptor Antagonist Reverses Key Alterations in Fragile X Syndrome Mouse Model. Genes 2016, 7, 56.
https://doi.org/10.3390/genes7090056
AMA Style
Gomis-González M, Busquets-Garcia A, Matute C, Maldonado R, Mato S, Ozaita A.
Possible Therapeutic Doses of Cannabinoid Type 1 Receptor Antagonist Reverses Key Alterations in Fragile X Syndrome Mouse Model. Genes. 2016; 7(9):56.
https://doi.org/10.3390/genes7090056
Chicago/Turabian Style
Gomis-González, Maria, Arnau Busquets-Garcia, Carlos Matute, Rafael Maldonado, Susana Mato, and Andrés Ozaita.
2016. "Possible Therapeutic Doses of Cannabinoid Type 1 Receptor Antagonist Reverses Key Alterations in Fragile X Syndrome Mouse Model" Genes 7, no. 9: 56.
https://doi.org/10.3390/genes7090056
APA Style
Gomis-González, M., Busquets-Garcia, A., Matute, C., Maldonado, R., Mato, S., & Ozaita, A.
(2016). Possible Therapeutic Doses of Cannabinoid Type 1 Receptor Antagonist Reverses Key Alterations in Fragile X Syndrome Mouse Model. Genes, 7(9), 56.
https://doi.org/10.3390/genes7090056